Starting the Conversation On Noise Aversion In Your Practice

In this 60-minute course, Dr. Jim Mathias (DVM, Owner, Medical Director) and Tara Fisher (RVT, CPDT-KA) from Tipp City Veterinary Hospital share how they have incorporated noise aversion in their practice, and how they initiate the conversation with pet owners.

Following Up With Patients On SILEO®(dexmedetomidine oromucosal gel)

In this 30-minute course, Dr. Jim Mathias (DVM, Owner, Medical Director) and Tara Fisher (RVT, CPDT-KA) from Tipp City Veterinary Hospital talk about the importance of following up with every pet, as well as how they respond to common client objections when prescribing SILEO® (dexmedetomidine oromucosal gel).

Noise Aversion in Dogs CE Course

It is estimated that 30-50% of dogs in the United States suffer from noise aversion cases in the clinic. Dr. Sara Bennett walks through the diagnosis challenges, treatment options and key takeaways of noise aversion in dogs.

Noise Aversion: A Case-Based Exploration of Treatment Options

In this webinar, Dr. Sara Bennett provides a clinically-relevant overview of noise aversion, including diagnosis and a review of currently available treatment options. In a case-based approach, Dr. Bennett discusses how to best develop a treatment plan based on patient and owner needs.

Noise Aversion Toolbox

Download these additional resources to assist in the diagnosis and treatment of noise aversion in dogs

Do not use SILEO in dogs with severe cardiovascular disease, respiratory, liver or kidney diseases, or in conditions of shock, severe debilitation, or stress due to extreme heat, cold or fatigue or in dogs hypersensitive to dexmedetomidine or to any of the excipients. SILEO should not be administered in the presence of preexisting hypotension, hypoxia, or bradycardia. Do not use in dogs sedated from previous dosing. SILEO has not been evaluated in dogs younger than 16 weeks of age or in dogs with dental or gingival disease that could have an effect on the absorption of SILEO. SILEO has not been evaluated for use in breeding, pregnant, or lactating dogs or for aversion behaviors to thunderstorms. Transient pale mucous membranes at the site of application may occur with SILEO use. Other uncommon adverse reactions included emesis, drowsiness or sedation. Handlers should avoid direct exposure of SILEO to their skin, eyes or mouth. Failure to lock the ring-stop on the syringe before dosing SILEO could potentially lead to an accidental overdose. Always review INSTRUCTIONS FOR USE before dispensing and dosing. See full prescribing information.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.